Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Personalis provides advanced genomic sequencing and analytics solutions to support the development of personalized cancer therapies, especially immunotherapies. Their proprietary ACE Technology enhances the accuracy of next-generation sequencing for comprehensive tumor profiling. The company partners with pharmaceutical firms to enable precision oncology through high-quality molecular data but does not develop its own therapeutics or run clinical trials as a sponsor.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Personalis.